ETHYL 3-BROMO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLATE, 95%, 5g

4-(4-METHYLPHENOXY)BENZYLAMINE HCL, 95.0%, 25g

4'-(4-Bromophenyl)-2,2':6',2''-terpyridine>97.0%(HPLC)(T)1g

2-(3-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95.0%, 1g

Ethyl 1H-pyrrolo[2,3-b]pyridine-5-carboxylate, 98%, 5g

(S)-4-Isopropyl-5,5-diphenyloxazolidin-2-one, 95.0%, 5g

8-Bromo-5-fluoroisoquinoline, 97%, 5g

N,N-dimethylacetamide, min. 99%, for synthesis, 250 ml, glass packaging

L-Tryptophanol, 90%, 1g

2-Chloro-4-methylpyrimidine, 98.0%, 25g

3-Methylpicolinic acid hydrochloride, 95.0%, 5g

HEXAMETHYLENE OXIDE, 95%, 1g

Ethyl 2-bromo-6-methyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylate, 95.0%, 250mg